1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2005236020 (hide)

Owner Merck & Co., Inc.

Inventors Stauffer, Shaun R.; Barrow, James C.; Coburn, Craig A.; McGaughey, Georgia B.; Selnick, Harold G.; Nantermet, Philippe G.; Rajapakse, Hemaka A.

Agent Spruson & Ferguson

Pub. Number AU-A-2005236020

PCT Pub. Number WO2005/103020

Priority 60/563,657 20.04.04 US

Filing date 15 April 2005

Wipo publication date 3 November 2005

International Classifications

C07D 271/10 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/103020 Priority application(s): WO2005/103020

11 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005236023-Truncated adamts molecules

2005236012-Fabric care composition comprising polymer encapsulated fabric or skin beneficiating ingredient